Stereotactic ablative radiotherapy for treating primary head and neck cancer and locoregional recurrence: A comprehensive review of the literature

CONCLUSIONS: SABR is an innovative, effective and promising treatment modality for small targets, especially in near proximity to organs at risk or in a pre-irradiated region. Prospective trials are further needed for this technique to become standard-of care.PMID:38590327 | PMC:PMC10999469 | DOI:10.1016/j.ctro.2024.100766
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research